Αρχική World News Working to Address Inequities in Cancer Care: 2021 ASCO Annual Meeting Reflections

Working to Address Inequities in Cancer Care: 2021 ASCO Annual Meeting Reflections

Equity was the focus of this year’s 2021 ASCO Annual Meeting, which took place online from June 4 to 8 and included over 30,000 participants. This theme resonated deeply with ASCO members and attendees after the events of the past year, with over 3.9 million lives lost to the COVID-19 pandemic worldwide, disruptions to all aspects of our daily lives, and the painful recognition of systemic racism in the United States. These dueling pandemics put a sharp focus on ASCO’s efforts to address health inequities in cancer care. As we make significant impacts in our understanding of cancer biology and bring new innovations to people with cancer at a dizzying pace, cancer care providers must commit to ensuring that everyone benefits from these advancements regardless of who they are and where they live.

There are several ways health inequities exist in cancer care. For example, it is well established that Black people with cancer fare much worse for most types of cancer compared with all other racial and ethnic groups. We also know that people with cancer in areas of rural America have difficulty accessing specialty care. So the current challenge in cancer care is that of inequity: treating every person fairly and being aware of the impact of societal circumstances on a person’s health.

To highlight some of the inequities that exist in cancer care, sessions during this year’s Annual Meeting included topics and new research in areas such as, “International Disparities in Gynecologic Malignancies,” “Use of an Antiracism Intervention to Decrease Disparities in Time to Lung Cancer Surgery,” and “Telehealth to Improve Oncology Care for Rural Communities.”

Equity was also the presidential theme for 2020–2021 ASCO President Lori J. Pierce, MD, FASTRO, FASCO. For ASCO, that means that every patient everywhere should receive cancer care that results in the best possible outcome. This is an easy concept to grasp, but addressing inequities in care requires education, deep collaboration, and unwavering intention.

For a person with cancer, this means that their health care team fully acknowledges the conditions in the place where they live, learn, work, and age. In health care, we call these the “social determinants of health.” Understanding an individual’s circumstances helps the health care team recognize potential barriers to care that might exist for them and provides opportunities to overcome those barriers.

Some examples of barriers that lead to inequities in cancer care include:

Transportation. If someone with cancer can’t get to health care facilities, they can’t get the clinical services they need. Transportation barriers include having long distances to travel to medical facilities (which is particularly common in rural areas), limited income, limited support networks, or public transportation that requires multiple transfers or does not drop off near the facility entrance.

Socioeconomic factors. Some people with cancer need care they can’t afford. Others must make choices between paying for insurance premiums and medications or paying for food, housing, and childcare.

Lack of cultural humility. This means that health care systems are sometimes unable or unwilling to acknowledge how someone’s culture or values influences their view of illness and health.

By developing systems and teams that can work to minimize these barriers to care, we can help people with cancer get the care they need. Many centers have incorporated systems to promote equity. For example, we know that having nurse navigators involved can lead to decreases in a person’s time to surgery. We have seen that we can leverage electronic health records to increase cancer screening. It has been proven that having health care providers who reflect the people we treat leads to improved communication and trust.

Equity in cancer care is deeply personal. It’s understanding how to meet a person with cancer where they are and knowing how to get them to the best outcome. By supporting research and innovation areas such as these, ASCO has been true to its mission: “Conquering cancer through research, education and promotion of the highest quality, equitable patient care.”



Συμπληρώστε το email σας για να λαμβάνετε τις σημαντικότερες ειδήσεις από το ogkologos.com

Βρείτε μας

2,449ΥποστηρικτέςΚάντε Like

Διαβαστε Επίσης

Καρκίνος και Κορωνοϊός (COVID-19) ΜΕΡΟΣ Α

Εάν είστε καρκινοπαθής, το ανοσοποιητικό σας σύστημα μπορεί να μην είναι τόσο ισχυρό όσο κανονικά, έτσι μπορεί να ανησυχείτε για τους κινδύνους που σχετίζονται...


Η Παγκόσμια Ημέρα Κατά του Καρκίνου καθιερώθηκε με πρωτοβουλία της Διεθνούς Ένωσης κατά του Καρκίνου (UICC), που εκπροσωπεί 800 οργανώσεις σε 155 χώρες του...


ΕΞΕΛΙΞΕΙΣ ΣΤΗ ΘΕΡΑΠΕΙΑ ΤΟΥ ΜΗ-ΜΙΚΡΟΚΥΤΤΑΡΙΚΟΥ ΚΑΡΚΙΝΟΥ ΤΟΥ ΠΝΕΥΜΟΝΑ (ΜΜΚΠ) Γράφει ο Δρ Παπαδούρης Σάββας, Παθόλογος-Ογκολόγος   Ο ΜΜΚΠ βρίσκεται αναλογικά στο 80% και πλέον του συνολικού...

Διατρέχουν όντως οι καρκινοπαθείς μεγαλύτερο κίνδυνο λόγω κοροναϊού;

Σε πρακτικό επίπεδο, τα δεδομένα των σχετικών μελετών υποδηλώνουν ότι η χημειοθεραπεία ή οι άλλες αντι-νεοπλασματικές θεραπείες δεν αυξάνουν σημαντικά τον κίνδυνο θνησιμότητας από...

FDA: Η ακτινοβολία των smartphones δεν προκαλεί καρκίνο

Σε μια νέα έκθεσή της, η Υπηρεσία Τροφίμων και Φαρμάκων (FDA) των ΗΠΑ αναφέρει ότι επανεξέτασε τις σχετικές επιστημονικές έρευνες που δημοσιεύθηκαν τα τελευταία...

Νέα ανακάλυψη, νέα ελπίδα για τον καρκίνο

Ένα νεοανακαλυφθέν τμήμα του ανοσοποιητικού μας συστήματος θα μπορούσε να αξιοποιηθεί για την αντιμετώπιση όλων των ειδών καρκίνου, σύμφωνα με επιστήμονες του πανεπιστημίου Cardiff...
- Advertisment -

Ροή Ειδήσεων

Combining existing drugs improves prostate cancer survival

Adding abiraterone to standard hormone therapy improves survival for men with high-risk prostate cancer that’s not spread elsewhere in the body. “Today’s results are the...

New Combination of Old Drugs Improves Survival in Patients with Prostate Cancer [ESMO Congress 2021 Press Release]

LBA4_PR - Abiraterone acetate plus prednisolone (AAP) with or without enzalutamide (ENZ) added to androgen deprivation therapy (ADT) compared to ADT alone for men...

Immunotherapy Prolongs Survival in Recurrent, Persistent or Metastatic Cervical Cancer [ESMO Congress 2021 Press Release]

LBA2_PR - Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for persistent, recurrent, or metastatic cervical cancer: Randomized, double-blind, phase 3 KEYNOTE-826 study N. Colombo1, C....

Woman Diagnosed with Breast Cancer at 33 Launches Self-Examination App

Jessica Baladad has had a long history with self-examinations after a breast cancer scare in her early 20s. This habit helped save her life,...

Extended Adjuvant Treatment with Letrozole Results in Longer Survival in Postmenopausal Patients with Breast Cancer

According to results from a prospective, open-label, phase III study conducted in 69 Italian hospitals within the Gruppo Italiano Mammella among the postmenopausal patients...

Foodie Fridays: Apple Bok Choy Salad

While the temps may still be in the 80’s, apple season is upon us! Give this Apple Bok Choy salad a try!  It is...